All lobbying filings

NELSON MULLINS RILEY & SCARBOROUGH

NELSON MULLINS RILEY & SCARBOROUGH filed a Q2 report for ANBEX, INC. on July 18, 2025, reporting $15,000 in lobbying income.

Lobbying for ANBEX, INC. · Pharmaceutical Manufacturing

All filings by NELSON MULLINS RILEY & SCARBOROUGH · Everything ANBEX, INC. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 18, 2025

Income

$15,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Stockpile potassium iodide to counteract effects of nuclear radiation.

Energy/Nuclear

The utilization of potassium iodide to protect against nuclear radiation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.